Patient-Reported Outcomes in Axial Spondyloarthritis

被引：15

作者：

Nhan, Derek T. ^{[1
,2
]}

Caplan, Liron ^{[1
,2
]}

机构：

[1] Vet Affairs Med Ctr, Denver, CO USA

[2] Univ Colorado, Sch Med, POB 6511,Mail Stop B115, Aurora, CO 80045 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2016年 / 42卷 / 02期

关键词：

Axial spondyloarthritis; Ankylosing spondylitis; Patient outcome assessment; BATH ANKYLOSING-SPONDYLITIS; QUALITY-OF-LIFE; DOUGADOS FUNCTIONAL INDEX; DISEASE-ACTIVITY INDEX; ACTIVITY SCORE ASDAS; HEALTH-ASSESSMENT QUESTIONNAIRE; CLASSIFICATION CRITERIA; SPINAL MOBILITY; VALIDATION; ASQOL;

D O I：

10.1016/j.rdc.2016.01.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Axial spondyloarthritis (axSpA), a subtype of spondyloarthritis, is a debilitating inflammatory condition involving the spinal and sacroiliac joints, contributing to a significant diminution in quality of life. Historically, characterization of patient outcomes in axSpA has been a challenge due to the lack of data from longitudinal epidemiologic studies and the nonspecific nature of inflammatory laboratory markers to monitor disease activity. In this review, measures developed to address these clinical domains are discussed and compared, of which 3 are commonly used in diagnosis and therapeutic planning. Provider data regarding utilization of these measures are also included to clarify current clinical practice trends.

引用

页码：285 / +

页数：16

共 56 条

[1]

AMOR B, 1990, REV RHUM, V57, P85

[2]

Biasi D, 1996, J RHEUMATOL, V23, P407

[3]

Boonen A, 2001, J RHEUMATOL, V28, P1056

[4]

Brandt J, 2003, Z RHEUMATOL, V62, P264, DOI 10.1007/s00393-003-0522-y

[5] International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis [J].

Braun, J ;

Pham, T ;

Sieper, J ;

Davis, J ;

van der Linden, S ;

Dougados, M ;

van der Heijde, D .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (09) :817-824

[6] CLINICAL HISTORY AS A SCREENING-TEST FOR ANKYLOSING-SPONDYLITIS [J].

CALIN, A ;

PORTA, J ;

FRIES, JF ;

SCHURMAN, DJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (24) :2613-2614

[7]

CALIN A, 1994, J RHEUMATOL, V21, P2281

[8] Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? [J].

Calin, A ;

Nakache, JP ;

Gueguen, A ;

Zeidler, H ;

Mielants, H ;

Dougados, M .

RHEUMATOLOGY, 1999, 38 (09) :878-882

[9]

Cardiel MH, 2003, CLIN EXP RHEUMATOL, V21, P451

[10]

Claudepierre P, 1997, J RHEUMATOL, V24, P1954

← 1 2 3 4 5 6 →